The market size of C-Arms in the North American region is forecasted to worth USD 2.10 billion by 2027. It is estimated to be USD 1.74 billion in 2022 and showcasing a CAGR of 3.78% between 2022 to 2027.
In North America, the prominence for C–arms' portability is increasing and provides enormous opportunities for the industries manufacturing small C-arms, which is a positive sign to the growth rate of the market. The rise in the prevalence of chronic diseases is another significant factor in driving the market. In the U.S., 567,614 deaths occurred because of cardiovascular diseases in 2010, and by 2015 it has increased up to 596,872. It is anticipated to escalate to 620,000 by 2020, according to the Center for Diseases Control and Prevention in 2017. Extensive usage of c-arms in medicine and their applications are proposed to increase over time.
Growing healthcare standards and technology advancements for imaging in the U.S. as it has the highest installed base of C-arms across the globe is propelling the region's market over the period. Rising assumption of small C-arms, an expected increase of osteoporosis, and rapid innovation in producing and modeling technologies stimulate market growth in the region during the analysis period. Rising awareness regarding the medical imaging equipment and monetary stability to own costly devices and increase investments to assist medical and healthcare development.
Usage of renovated devices and increasing cost issues are impeding the c-arms market in the region over the period. Low substitution rates for c-arms is one such factor restraining the growth in the market.
This research report on the North America C-Arms Market has been segmented and sub-segmented into the following categories:
By Device type:
In 2020, North America C-Arms Market led the global C-Arms market in terms of both value and capacity. The market in this region is projected to grow strongly during the forecast period due to various factors such as growing awareness about medical imaging tools, financial strength to procure expensive devices, and adopting advanced products.
The United States C-Arms Market is expected to have the largest market share due to high healthcare infrastructure standards. In the U.S., the death rate is escalating owing to cardiovascular diseases, and the pressure for c-arm imaging equipment is predicted to augment the market growth. Increasing the high frequency of diagnostic examination and expanding the aging population are boosting the market.
Canada C-Arms Market is expected to showcase promising and notable growth in the region. Increasing familiarity in minimally invasive surgeries and utilizing these C-arms is extended to assist spinal surgery, cardiac, urology neurovascular applications, and vascular surgery. 46.0% of adults in the U.S. suffer from hypertension every year, according to the American Heart Association (AHA).
Companies playing a dominant role in the North America C-Arms Market profiled in this report are GE Healthcare Inc., Varian Medical Systems Inc., Philips Healthcare, Siemens AG, Toshiba Corp., Hologic corp., Omega Medical Imaging Inc., BMI Biomedical International, Hitachi Ltd., DMS Health Technologies, ATON GmbH, Medonica Co Ltd., Gemss Co Ltd., and Shimadzu Corp.
The market is highly consolidated due to the high prices of equipment, and a considerable amount of capital is required for the entry of a new company into the market. It has led to formidable competition among prominent market players.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org